SCHEMBL3135474

SCHEMBL3135474

C=CCN1C(=O)SC(=Cc2ccc(-c3ccccc3)o2)C1=S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPT P10636 3/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
RAB9A P51151 1/20 0.54
ITGB2 P05107 2/20 0.53
ITGAM P11215 2/20 0.53
PIK3CG P48736 1/20 0.49
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
EP300 Q09472 1/20 0.45
CREBBP Q92793 1/20 0.45
STAT3 P40763 1/20 0.44
CDC25B P30305 1/20 0.44
ENPP2 Q13822 1/20 0.44
APEX1 P27695 1/20 0.44
HIF1AN Q9NWT6 1/20 0.43
MAP3K5 Q99683 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3135468 1.00 POLB (0.58) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3135461 1.00 POLB (0.58) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3134579 0.88 MEN1 (0.63) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL17933299 0.88 POLB (0.63) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3134591 0.88 MEN1 (0.63) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3134585 0.88 MEN1 (0.63) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3133007 0.86 ITGB2 (0.60) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3133014 0.86 ITGB2 (0.60) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3133011 0.86 ITGB2 (0.60) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL3135868 0.85 MAPT (0.55) POLBMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 POLB 4238/4885MEN1 4512/4885KMT2A 2561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.